Customized service

We will provide you with approaches and services tailored to your needs We provide business support in several therapeutic areas, especially emerging oncology therapies

Prioritized therapeutic areas

  1. Oncology
  2. Neurology
  3. Dermatology
  4.  Respiratory

Prioritized therapeutic modalities and technology platforms

  1. Chimeric antigen receptor (CAR-T and CAR-NK) cell therapies
  2. Messenger RNA & Gene editing
  3. Antibody-drug conjugates
  4. Immune checkpoint inhibitors
  5. Breakthrough new platforms (Suppressor tRNA, …)

Clinical stage

  1. Early stage innovative technology platforms for drug discovery and drug development (NME)
  2. Clinical stage assets (Ph1, Ph2 or Ph3) with promising clinical outcomes and/or with breakthrough designation, fast track designation, RMAT designation or PRIME designation
  3. Breakthrough therapies/drugs marketed in EU and/or US with large market and need in CN and with good IP coverage in CN